John Villano
Director, Clinical Neuro-Oncology · University of Kentucky College of Medicine
Credentials: · · · · · ·
History
- 1997–2000
Internal Medicine
Research
Epidemiologic and molecular prognostic review of glioblastoma
Review · Cancer Epidemiology · 2014 · Last of 7 authors · Corresponding · 1,019 citations
European Journal of Cancer · 2012 · 661 citations
Age, gender, and racial differences in incidence and survival in primary CNS lymphoma
British Journal of Cancer · 2011 · First of 5 authors · Corresponding · 445 citations
15 papers
- HE
10 papers
10 papers
9 papers · 7 as a resident
9 papers
- RM
7 papers
6 papers · 2 as a fellow
6 papers
Grants
- 2013–2016
Clinical Characteristics and Patterns of Care for Rare Brain Tumor Sub-Types
National Cancer Institute · R03
Contact PI · $160.7K · University of Kentucky
Clinical trials
- 2022–2023
- 2019–2025
Durvalumab and Tremelimumab Combination in Somatically Hypermutated Recurrent Solid Tumors
Principal investigator · Completed · Phase 2
John L. Villano, MD, PhD
- 2017–2026
Priming Immunotherapy in Advanced Disease With Radiation
Principal investigator · Completed · Phase 2
John L. Villano, MD, PhD
- 2016–2022
NovoTTF-100A Therapy for Refractory CNS Involved Small Cell Lung Cancer
Principal investigator · Withdrawn · Phase 2
John Villano